Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: A retrospective observational study

Dexmedetomidine, a selective α(2)-agonist, reduces cerebral blood flow and has neuroprotective effects against cerebral ischemia/reperfusion injury in experimental animals. We examined whether intraoperative dexmedetomidine would reduce the incidence of postoperative cerebral hyperperfusion syndrome...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Main Authors: Seo, Hyungseok, Ryu, Ho-Geol, Son, Je Do, Kim, Jeong-Soo, Ha, Eun Jin, Kim, Jeong-Eun, Park, Hee-Pyoung
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer Health 2016
Assuntos:
3300
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5207568/
https://ncbi.nlm.nih.gov/pubmed/28033272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005712
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares